Sign Up to Receive Your Personalised Learning Resources
Start Learning
Migraine prevention in the real world: Exploring the role of anti-CGRP antibodies
Stewart Tepper, AAN 2023: Results from the PRODROME trial of ubrogepant for the acute treatment of migraine
Peter Goadsby, EAN 2023: Highlights in migraine
Optimizing the management of patients with relapsing forms of MS: An update on emerging treatment options
Wellness in Parkinson’s Disease: A Framework for Management Using a Holistic Culturally Sensitive Approach
Updates in the Use of Vamorolone and Steroids in the Treatment of Duchenne Muscular Dystrophy
Simon Faissner, EAN 2023: Safety and efficacy of diroximel fumarate in older patients with multiple sclerosis from the phase III EVOLVE-MS-1 study
Pridopidine: Topline Results from the Phase III Trial, PROOF-HD, for the Treatment of Huntington’s Disease
The Future of SCN1A Gene-targeting Research for the Treatment of Dravet Syndrome
Stewart Tepper, AAN 2023: Significant reduction in migraine days with REN for migraine prevention: A double-blind randomized sham-controlled clinical trial
Sign up to view Favourites, Keep Notes and Track CME Credits
Favourites
Updates in the Use of Vamorolone and Steroids in the Treatment of Duchenne Muscular Dystrophy
View
Anthony Béhin, EAN 2023: Highlights in myasthenia gravis
View
An Overview of a Stepped-care Approach to Modern Holistic and Subtype-driven Care for Parkinson’s Disease in the Clinic
View
Stewart Tepper, AAN 2023: Combination of rizatriptan and AXS-07 – results from the MOMENTUM and INTERCEPT studies
View
Enrique Alvarez, AAN 2023: Ublituximab for participants with relapsing multiple sclerosis
View
Sabrina Sacconi, EAN 2023: Highlights in myasthenia gravis
View
Present and Future of Biomarkers for Accurate Diagnosis of Alzheimer’s Disease: Integrating Clinical and Biomarker Assessments for a Timely and Accurate Diagnosis
View
Discovery of ketamine to treat psychiatric disorders targeting monoamine signaling: John Krystal, APA 2023
View
Advances in the early diagnosis and treatment of Alzheimer’s disease
View
Paradoxical Tumefactive Worsening of Multiple Sclerosis After Natalizumab Initiation: A Case Report
View